Product logins

Find logins to all Clarivate products below.


: Dealmaking

Here you will find relevant articles and insight into all Clarivate related products and news.

BioWorld at 35: a legacy of trusted journalism, a future of innovation BioWorld at 35: a legacy of trusted journalism, a future of innovation
Blog September 17, 2025
BioWorld at 35: a legacy of trusted journalism, a future of innovation
Biopharma Biotech Dealmaking
Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Biopharma Bioworld Business Development
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Biopharma Bioworld Business Development
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Biopharma Bioworld Business Development
Blog September 24, 2018
Key Q2 partnerships driving biopharma
APAC Asia Biopharma
Blog September 11, 2018
Life sciences M&As in the second quarter of 2018: notes, trends and a closer look at APAC
APAC Biopharma Cortellis
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Biopharma deals Bioworld Cortellis
Blog February 22, 2018
Cancer, neurology, immune therapies drive continued robust pace of biopharma financings
Bioworld Cortellis Cortellis Deals Intelligence

Dealmaking

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
BioWorld at 35: a legacy of trusted journalism, a future of innovation BioWorld at 35: a legacy of trusted journalism, a future of innovation
Blog September 17, 2025
BioWorld at 35: a legacy of trusted journalism, a future of innovation
Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Blog September 24, 2018
Key Q2 partnerships driving biopharma
Blog September 11, 2018
Life sciences M&As in the second quarter of 2018: notes, trends and a closer look at APAC
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Blog February 22, 2018
Cancer, neurology, immune therapies drive continued robust pace of biopharma financings
Blog February 15, 2018
Life sciences M&A deals in the fourth quarter of 2017: updates and trends
Blog January 30, 2018
Ingredients for a ‘good deal’ in biopharma? Ambition, creativity, win-wins, cool science, cross-border intrigue